期刊文献+

多烯磷脂酰胆碱对胃癌奥沙利铂耐细胞株BGC823/L-OHP耐药逆转作用的研究

Effect of polyene phosphatidylcholine on reversing drug-resistance in human oxaliplatin-resistant gastric cancer cell line BGC823/L-OHP
下载PDF
导出
摘要 目的探讨多烯磷脂酰胆碱(PPC)对胃癌耐奥沙利铂(L-OHP)细胞株BGC823/L-OHP的增殖抑制、逆转耐药作用及可能机制。方法采用CCK-8法检测不同浓度PPC(0、0.5、1.5、3、6、12、24、48、64、86μmol/L)处理BGC823/L-OHP细胞的增殖率,并检测不同浓度PPC(1、5、10μmol/L)联合不同浓度L-OHP(1、5、10、20、30、40μg/ml)处理BGC823细胞和BGC823/L-OHP细胞48 h的增殖抑制率,检测L-OHP的半数抑制浓度(IC_(50))和逆转耐药作用,同时选取IC_(50)最小时PPC浓度作为后续实验浓度。实时荧光定量PCR(QPCR)和Western blotting检测Toll样受体-4(TLR-4)、Nanog和ABCF2的mRNA和蛋白表达情况。结果 0.5~48μmol/L PPC能促进BGC823/L-OHP细胞增殖,64、86μmol/L PPC可抑制BGC823/L-OHP细胞增殖。经PPC处理,L-OHP作用48 h的IC_(50)由28.54μg/ml下降至6.63μg/ml,逆转倍数为4.31。5μmol/L PPC能显著增加L-OHP对BGC823/L-OHP细胞的敏感性,选取该浓度用于后续实验。与BGC823组比较,BGC823/L-OHP组中ABCF2、TLR-4和Nanog的mRNA和蛋白水平显著上调(P<0.05);经5μmol/L PPC处理后,BGC823/L-OHP组中ABCF2、TLR-4和Nanog的mRNA和蛋白水平显著下调(P<0.05)。结论 PPC联合L-OHP能够增加BGC823/L-OHP细胞株对L-OHP的敏感性,抑制细胞生长,从而逆转耐药。其机制可能是通过影响TLR-4、Nanog和ABCF2表达来发挥逆转耐药的作用。 Objective To investigate the proliferative inhibitory effect and reversal of oxaliplatin( L-OHP) resistance of polyene phosphatidylcholine( PPC) on gastric cancer BGC823/L-OHP cells and its possible mechanism. Methods CCK-8 assay was used to detect the effect of PPC( 0,0. 5,1. 5,3,6,12,24,48,64,86 μmol/L) on the proliferation of BGC823/L-OHP cells. Meanwhile,the effect of PPC( 1,5,10 μmol/L) in combination with L-OHP( 1,5,10,20,30,40 μg/ml) on the proliferation of BGC823 cells and BGC823/L-OHP cells at 48 h was detected by CCK-8 assay. The effect of reversing drug resistance and the half maximal inhibitory concentration( IC50) of L-OHP were determined. The minimum IC50 of PPC was chosen for the following experiment.The expressions of Toll like receptor-4( TLR-4),Nanog and ABCF2 mRNA and protein were detected by QPCR and Western blotting.Results Low concentration of PPC( 0. 5-48 μmol/L) could promote the proliferation of BGC823/L-OHP cells, but high concentration of PPC( 64,86 μmol/L) could inhibit the proliferation of BGC823/L-OHP cells. The reversal effect of 5 μmol/L PPC was the most obvious. With the treatment of PPC,the IC50 of L-OHP on BGC823/L-OHP cells decreased from 28. 54 μg/ml to 6. 63μg/ml,and the reverse index was 4. 31. The concentration of 5 μmol/L PPC could significantly increase the sensitivity of BGC823/LOHP cells to L-OHP. Compared with BGC823 group,the expressions of ABCF2,TLR-4 and Nanog mRNA and protein in BGC823/LOHP group were significantly up-regulated( P〈0. 05),and ABCF2,TLR-4 and Nanog mRNA and protein levels were significantly down-regulated after 5 μmol/L PPC treatment( P〈0. 05). Conclusion PPC in combination with L-OHP can increase the sensitivity of BGC823/L-OHP cells to L-OHP,inhibit the growth of BGC823/L-OHP cells and reverse the drug resistance. Its mechanism may play a role in reversing drug resistance by affecting the expression of TLR-4,Nanog and ABCF2.
作者 袁荣辉 张红军 高蕾 姚如勇 鞠兴艳 YUAN Ronghui;ZHANG Hongjun;GAO Lei;YAO Ruyong;JU Xingyan(Clinical College of Medical College,Qingdao University,Qingdao 266021,China)
出处 《临床肿瘤学杂志》 CAS 北大核心 2018年第4期305-309,共5页 Chinese Clinical Oncology
关键词 胃癌 BGC823/L-OHP细胞 奥沙利铂(L-OHP) 多烯磷脂酰胆碱(PPC) 逆转耐药 Gastric cancer BGC823 / L-OHP cells Oxaliplatin(L-OHP) Polyene phosphorylcholine(PPC) Reverse drug resistance
  • 相关文献

参考文献3

二级参考文献63

  • 1Medvedev AE. Toll-like receptor polymorphisms, inflammatory and infectious diseases, allergies, and cancer[J]. J Interferon Cytokine Res, 2013, 33(9): 467-484.
  • 2Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity[J]. Nature, 1997, 388(6640): 394-397.
  • 3Temperley ND, Berlin S, Paton IR, et al. Evolution of the chicken Toll-like receptor gene family: a story of gene gain and gene loss[J]. BMC Genomics, 2008, 9: 62.
  • 4Barbalat R, Lau L, Locksley RM, et al. Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands[J]. Nat Immunol, 2009, 10(11): 1200-1207.
  • 5Kang S, Lee SP, Kim KE, et al. Toll-like receptor 4 in lymphatic endothelial cells contributes to LPS-induced lymphangiogenesis by chemotactic recruitment of macrophages[J]. Blood, 2009, 113(11): 2605-2613.
  • 6Ren W, Wang Z, Hua F, et al. Plasminogen activator inhibitor-1 regulates LPS-induced TLR4/MD-2 pathway activation and inflammation in alveolar macrophages[J]. Inflammation, 2015, 38(1): 384-393.
  • 7Thada S, Valluri VL, Gaddam SL. Influence of Toll-like receptor gene polymorphisms to tuberculosis susceptibility in humans[J]. Scand J Immunol, 2013, 78(3): 221-229.
  • 8Lin YC, Huang DY, Chu CL, et al. The tyrosine kinase Syk differentially regulates Toll-like receptor signaling downstream of the adaptor molecules TRAF6 and TRAF3[J]. Sci Signal, 2013, 6(289): ra71.
  • 9Madera-Salcedo IK, Cruz SL, Gonzalez-Espinosa C. Morphine prevents lipopolysaccharide-induced TNF secretion in mast cells blocking IkappaB kinase activation and SNAP-23 phosphorylation: correlation with the formation of a beta-arrestin/TRAF6 complex[J]. J Immunol, 2013, 191(6): 3400-3409.
  • 10Sina C, Arlt A, Gavrilova O, et al. Ablation of gly96/immediate early gene-X1 (gly96/iex-1) aggravates DSS-induced colitis in mice: role for gly96/iex-1 in the regulation of NF-kappaB[J]. Inflamm Bowel Dis, 2010, 16(2): 320-331.

共引文献117

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部